内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV · Nasdaq · CIK 0001801170 · Healthcare · Healthcare Plans

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

35 同一窗口内观察到的 Form 4 交易行
29 sales · 6 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2025-08-13 · Loengard Anna U · $68.8K

为什么没有活跃信号？

买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Reynoso Jamie L.CEO, Medicare Advantage
▼▼▼▼▼▼▼▼▼▼▼
Soares KarenChief Legal Officer
▼▼▼○▼
Toy AndrewChief Executive Officer
▼▼▼▼
OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER
▼▼▼
Wai ConradCEO, Counterpart Health
▼▼▼
THORNTON JOSEPH CLAYInterim CFO
▼○▼
● 买入▼ 卖出○ 其他

Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后，这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-13 · Loengard Anna U.

近期 Form 4 活动

0买入
35卖出
58其他 Form 4 交易行
83SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出29 sale line(s) · 仅供背景
其他6 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
22,900,620
上期报告
23,446,183
日均成交量
3,632,140
回补天数
6.3

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2025-08-13Loengard Anna U买入 (P)Class A Common Stock26,500USD 2.59USD 68,755SEC 申报 ↗
2025-08-08Garipalli Vivek买入 (P)Class A Common Stock31,980USD 2.17USD 69,397SEC 申报 ↗
2025-08-07Garipalli Vivek买入 (P)Class A Common Stock415,000USD 2.24USD 929,600SEC 申报 ↗
2024-08-09Garipalli Vivek买入 (P)Class A Common Stock531,700USD 1.88USD 999,596SEC 申报 ↗
2024-06-17Garipalli Vivek买入 (P)Class A Common Stock877,567USD 1.14USD 1,000,426SEC 申报 ↗
2024-05-17Loengard Anna U买入 (P)Class A Common Stock10,000USD 0.93USD 9,300SEC 申报 ↗
2024-05-16Loengard Anna U买入 (P)Class A Common Stock17,085USD 0.96USD 16,372SEC 申报 ↗
2024-03-14Loengard Anna U买入 (P)Class A Common Stock150,625USD 0.73USD 109,956SEC 申报 ↗
2023-09-06Loengard Anna U买入 (P)Class A Common Stock10,500USD 1.30USD 13,650SEC 申报 ↗
2022-03-11SHAPIRO LEE买入 (P)Class A Common Stock80,000USD 3.10USD 248,000SEC 申报 ↗
2022-03-03Clinton Chelsea买入 (P)Class A Common Stock100,000USD 2.53USD 253,000SEC 申报 ↗
2021-11-22ChaChaCha SPAC C, LLC; Palihapitiya Chamath; SCH Sponsor III LLC买入 (P)Class A Common Stock1,739,130USD 5.75USD 9,999,998SEC 申报 ↗

Form 4 申报证据

93 transaction lines in the latest 365-day window; 350 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-10-07Reynoso Jamie L.卖出 (S)Class A Common Stock2,006USD 4.63USD 9,288SEC 申报 ↗
2026-10-05Reynoso Jamie L.卖出 (S)Class A Common Stock8,750USD 4.42USD 38,675SEC 申报 ↗
2026-10-01Toy Andrew卖出 (S)Class A Common Stock318,806USD 4.19USD 1,335,797SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-10-07Reynoso Jamie L.卖出 (S)Class A Common Stock2,006USD 4.63USD 9,288SEC 申报 ↗
2026-10-05Reynoso Jamie L.卖出 (S)Class A Common Stock8,750USD 4.42USD 38,675SEC 申报 ↗
2026-10-01Toy Andrew卖出 (S)Class A Common Stock318,806USD 4.19USD 1,335,797SEC 申报 ↗
2026-09-30Torricelli Robert G奖励／授予 (A)Class A Common Stock12,481USD 0.00USD 0SEC 申报 ↗
2026-09-30Miller Brian James奖励／授予 (A)Class A Common Stock12,481USD 0.00USD 0SEC 申报 ↗
2026-09-17Reynoso Jamie L.卖出 (S)Class A Common Stock1,921USD 4.56USD 8,760SEC 申报 ↗
2026-09-16OLDAKOWSKI JOSEPH FRANK卖出 (S)Class A Common Stock3,170USD 4.64USD 14,709SEC 申报 ↗
2026-09-15Wai Conrad卖出 (S)Class A Common Stock300,000USD 4.72USD 1,416,000SEC 申报 ↗
2026-09-15Soares Karen卖出 (S)Class A Common Stock6,846USD 4.78USD 32,724SEC 申报 ↗
2026-09-15Reynoso Jamie L.卖出 (S)Class A Common Stock9,273USD 4.78USD 44,325SEC 申报 ↗
2026-09-14OLDAKOWSKI JOSEPH FRANK卖出 (S)Class A Common Stock20,000USD 5.16USD 103,200SEC 申报 ↗
2026-08-17THORNTON JOSEPH CLAY卖出 (S)Class A Common Stock17,775USD 4.39USD 78,032SEC 申报 ↗
2026-08-12THORNTON JOSEPH CLAY奖励／授予 (A)Class A Common Stock54,347USD 0.00USD 0SEC 申报 ↗
2026-08-12Soares Karen奖励／授予 (A)Class A Common Stock108,695USD 0.00USD 0SEC 申报 ↗
2026-08-10Toy Andrew卖出 (S)Class A Common Stock87,798USD 4.65USD 408,261SEC 申报 ↗
2026-07-20Soares Karen卖出 (S)Class A Common Stock51,700USD 4.51USD 233,167SEC 申报 ↗
2026-07-17Reynoso Jamie L.卖出 (S)Class A Common Stock4,839USD 4.53USD 21,921SEC 申报 ↗
2026-07-15Wai Conrad卖出 (S)Class A Common Stock24,215USD 4.67USD 113,084SEC 申报 ↗
2026-07-15Toy Andrew卖出 (S)Class A Common Stock62,711USD 4.67USD 292,860SEC 申报 ↗
2026-07-15THORNTON JOSEPH CLAY卖出 (S)Class A Common Stock4,630USD 4.67USD 21,622SEC 申报 ↗
2026-07-15Soares Karen卖出 (S)Class A Common Stock10,519USD 4.67USD 49,124SEC 申报 ↗
2026-07-15Reynoso Jamie L.卖出 (S)Class A Common Stock13,119USD 4.67USD 61,266SEC 申报 ↗
2026-07-08Reynoso Jamie L.卖出 (S)Class A Common Stock2,384USD 4.68USD 11,157SEC 申报 ↗
2026-07-06Reynoso Jamie L.卖出 (S)Class A Common Stock6,229USD 5.26USD 32,765SEC 申报 ↗
2026-07-01Toy Andrew卖出 (S)Class A Common Stock313,476USD 5.32USD 1,667,692SEC 申报 ↗
2026-06-17Reynoso Jamie L.卖出 (S)Class A Common Stock2,360USD 4.78USD 11,281SEC 申报 ↗
2026-06-16OLDAKOWSKI JOSEPH FRANK卖出 (S)Class A Common Stock12,102USD 4.86USD 58,816SEC 申报 ↗
2026-06-15Soares Karen卖出 (S)Class A Common Stock4,681USD 4.61USD 21,579SEC 申报 ↗
2026-06-15Reynoso Jamie L.卖出 (S)Class A Common Stock6,350USD 4.61USD 29,274SEC 申报 ↗
2026-06-11Reynoso Jamie L.卖出 (S)Class A Common Stock7,289USD 4.91USD 35,789SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码CLOV
CIK0001801170
行业Healthcare
细分行业Healthcare Plans Yahoo Finance
SEC SIC6324 Hospital & Medical Service Plans
交易所Nasdaq

数据覆盖

本地 Form 4 历史350 transaction lines from 2021-01-07 to 2026-10-07
16 P purchase lines · 48 S sale lines · 286 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.